Detalles de la búsqueda
1.
Risk factors for endocrine complications in transfusion-dependent thalassemia patients on chelation therapy with deferasirox: a risk assessment study from a multi-center nation-wide cohort.
Haematologica
; 107(2): 467-477, 2022 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33406815
2.
Switching from dispersible to film coated tablet formulation of deferasirox improves hemoglobin levels and transfusional interval in patients with transfusion-dependent-thalassemia.
Br J Haematol
; 189(2): e60-e63, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32119115
Resultados
1 -
2
de 2
1
Próxima >
>>